Abstract: The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepine compounds of formula (I)-(VII). The invention also provides conjugates of the benzodiazepine compounds linked to a cell-binding agent. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention.

Abstract: Disclosed are nanoparticles comprising octapod iron oxide having eight trigonal bipyramidal arms and a method of preparing the same. The nanoparticles are prepared by heating a mixture of a ferric carboxylate, a carboxylic acid, a chloride salt, water, and a non-polar solvent, to a temperature above about 300° C. Also disclosed is a method of magnetic resonance imaging a tissue in a mammal, comprising use of the aforesaid nanoparticles.

Abstract: Compounds as defined herein are provided which are useful in (1) diagnostic methods for detecting and/or identifying cells presenting PSMA; (2) compositions comprising a compound of the invention together with a pharmaceutically acceptable diluent; and (3) methods for imaging prostate cancer cells.

Abstract: The present invention encompasses compositions comprising two spectrally distinct radionuclides separated by a site susceptible to cleavage. Compositions of the invention may be used to detect enzyme activity and/or image diseases associated with said enzyme activity.

Abstract: According to one implementation an assembly is provided that includes an optical fiber having a length and an infusion shaft having a lumen in which at least a first portion of the length of the optical fiber resides. A hub that is connected to the infusion shaft has a channel that houses at least a second portion of the length of the optical fiber. T second portion of the length of the optical fiber is not held taut along at least a portion of the length of the channel.

Abstract: Methods and apparatus to reduce biological carryover using induction heating are disclosed herein. An example method includes washing an aspiration and dispense device. The example method includes generating an alternating electromagnetic field and introducing the aspiration and dispense device into the alternating electromagnetic field. In the example method, the washing is to occur prior to introducing the aspiration and dispense device into the alternating electromagnetic field. The example method includes inductively heating the aspiration and dispense device with the alternating electromagnetic field.

Abstract: A germicidal system for use in disinfecting a human interface device includes at least one human interface device. One or more ultra-violet (UV) light sources are used in proximity to the at least one human interface device for disinfecting a touch surface of the human interface device below a surgical grade sterilization. A memory for storing usage data of the at least one UV light source. At least one server is used for providing a central storage location for usage data supplied from the memory and a computer is used in communication with the at least one server for controlling the operational parameters of the at least one UV light source.

Abstract: A multi-functional cutlery sterilizer, having a heating panel and a heating tube, operable via a press button panel of a main control device, so that the sterilization chamber can reach a high temperature to achieve sterilization. Also, a UV sterilization device is provided; by placing cutlery in the sterilization chamber and operating the UV sterilization device via the press button panel, UV light will illuminate and achieve UV sterilization. The cutlery sterilizer is additionally provided with UV sterilization, thereby providing an additional means for sterilization and thus equipping itself with more powerful functions. The sterilizer can sterilize cutlery made of different materials and therefore has a wider applicability. Further, cutlery not suitable for high temperature sterilization can be sterilized by UV sterilization.

Abstract: A sterilizer for point-of-sale credit card readers and keypads. One or more UV-C LEDs are integrated into the housing of the unit and directed at the keypad or other surface. The LED lights shine on the keypad or other contact surfaces, such as a stylus. Because LEDs use low DC voltage, the electronics may be powered by the keypad device power supply. The electronic circuits may be designed so that the LEDs are automatically turned on after each transaction is complete for a predetermined amount of time to kill the vast majority of pathogens that could be transmitted from person to person. The LEDs may be arranged on both the left and right side of the keypad, and at the top edge of the keypad to illuminate all exposed surfaces of the keys.

Abstract: A system for the disinfection of rooms and surfaces including at least one plate which can be associated with a room to be treated and equipped with a memory containing a plurality of identification data of the room and at least one diffuser device including a tank containing a liquid solution and nebulising means associated with the tank and designed to draw out the liquid solution from the tank spraying it in the space. The diffuser device includes a control unit associated with the nebulising means and which can be associated with the plate, designed for receiving from the plate a signal representing identification data of the room and designed for controlling the nebulising means as a function of the signal in such a way as to sanitise the room in an automatic manner.

Abstract: A solution for disinfecting electronic devices is provided. An ultraviolet radiation source is embedded within an ultraviolet absorbent case. While the electronic device is within the ultraviolet absorbent case, ultraviolent radiation is directed at the electronic device. A monitoring and control system monitors a plurality of attributes for the electronic device, which can include: a frequency of usage for the device, a biological activity at a surface of the device, and a disinfection schedule history for the device. Furthermore, the monitoring and control system can detect whether the device is being used. Based on the monitoring, the monitoring and control system controls the ultraviolet radiation directed at the electronic device.

Abstract: The scent-dispensing animal collar accessory is adapted for use with a collar that is worn by an animal. The scent-dispensing animal collar accessory is a container that is attached to the collar. The container is used to contain a fragrance device. The fragrance device is a chemical device that releases one or more aroma compounds. Air flow through the container will disperse the one or more aroma compounds into the atmosphere in a manner that deemphasizes existing aromas that may be associated with the animal. The scent-dispensing animal collar comprises a container, an attachment device, and a fragrance device.

Abstract: A catalytic fragrance burner assembly, comprising: a porous core of sintered material; a catalyst, deposited on or around the core; and a wick, in communication with the porous core, and arranged to draw fuel to the core.

Abstract: An apparatus (100 and/or 200) and corresponding method (500) for air sterilization and disinfection can include an electronics and control module (110 and/or 210), a means for drawing air from the surrounding environment into the apparatus (120 and/or 220), an air management chamber (130 and/or 230), and a housing (170 and/or 270). The means for drawing air from the surrounding environment into the apparatus (120 and/or 220) mobilizes latent pathogens in the environment and draws them into the apparatus (100 and/or 200) for sterilization and disinfection. The air management chamber (130 and/or 230) provides for exposure of the airborne pathogens to UV radiation, via UV LEDs (150 and/or 250), with a dosage sufficient to penetrate the cell walls and destroy the pathogens. The electronics and control module (110 and/or 210) powers the apparatus (100 and/or 200) and interfaces with the electronic components. The housing (170) forms the outer shell of the apparatus (100).

Abstract: The present invention relates to an air cleaning apparatus comprising a UVLED, which can efficiently clean air flowing in tubes by an effective combination of the UVLED and a photocatalyst and can effectively clean air flowing in a duct by enhancing the cleaning function or increasing the number of cleaning steps when the concentration of harmful substances increases. The air cleaning apparatus includes: a case comprising an inlet configured to introduce air, an outlet configured to discharge air, and a duct disposed between the air inlet and the air outlet; a photocatalyst unit disposed in the duct; and a UVLED module disposed in the duct and including a plurality of first UVLEDs arranged to irradiate UV light from the side of the inlet to the side of the outlet.

Abstract: [Problem] To provide a dust reducer which suppresses blocking against moisture absorption and has a reduced amount of dust generation, without impairing the water absorption physical properties that are required from a water absorbing agent, such as water absorption capacity under load; a method for producing a water absorbing agent using the dust reducer; and a water absorbing agent in which blocking against moisture absorption is suppressed and which has a reduced amount of dust generation. [Solution] A dust reducer for a water absorbing agent containing a surface crosslinked polyacrylic acid (salt)-based water absorbent resin as a main component, wherein the dust reducer is a multi-component metal compound which has a hydrotalcite structure and contains a hydroxyl group and two kinds of metal cations that are divalent and trivalent.

Abstract: The present invention provides processes for combined applications of making grooves on an implant surface, applying MgO nanoparticles with PMMA cement, restricting the cement movement by PCL nanofiber and tethering biomolecules with PCL nanofiber to enhance mechanical stability and osseointegration of PMMA cement with bone. This is achieved through enhanced osteoconductive properties, roughness, and less viable fracture originating sites at the bone-cement interface. Such combined applications of nanoparticle and nanofiber on the mechanical stability and osseointegration of cemented implant is heretofore unknown, but as provided by the present invention can solve the debonding problem of cemented implant from bone.

Abstract: Provided is a bone regeneration agent comprising an inactivated cell construct derived from stem cells as a source material, the inactivated cell construct at least containing a mineral and an extracellular matrix. The bone regeneration agent has osteoconductive and osteoinductive abilities, and is inexpensively producible and size-controllable. Also provided is a method comprising the steps of: (1) inducing differentiation of stem cells into mineral-producing cells in agitated culture under the condition of 0.01 to 1.00 Hz to give a cell aggregate at least containing a mineral and an extracellular matrix, or (1?) inducing differentiation of stem cells genetically engineered to overexpress a protein associated with bone formation into mineral-producing cells in agitated or static culture, to give a cell aggregate at least containing a mineral and an extracellular matrix, and (2) inactivating the cell aggregate obtained in the preceding step.

Abstract: Provided are tri-component matrices having collagen, hyaluronan, and chondroitin sulfate. Also provided are processes for producing a tri-component matrix. Additionally, provided are processes for providing cells capable of producing cartilage to a bone or cartilage defects.

Abstract: Method of manufacturing hydrogel microparticles comprising one or more species of living cells attached thereon and/or encapsulated therein is provided. The method includes dissolving a hydrogel-forming agent in an aqueous medium to form a solution; suspending one or more species of living cells in the solution to form a cell suspension; dispersing the cell suspension into an organic oil to form a microemulsion; and subjecting the microemulsion to conditions that allow the hydrogel-forming agent to form hydrogel microparticles comprising one or more species of living cells attached thereon and/or encapsulated therein. Composition comprising a mixture of a degradable hydrogel and at least one hydrogel microparticle having one or more species of living cells, and method of manufacturing a scaffold for tissue engineering are also provided.

Abstract: Apparatus and methods are provided for creating tubular devices, e.g., as components for catheters, sheaths, and or other devices sized for introduction into a patient. In one embodiment, a method is provided for making a tubular device using a sheet of material including a coated first surface. The sheet is rolled around a mandrel until longitudinal edges of the sheet are disposed near or adjacent one another, e.g., without attaching the longitudinal edges together. A tubular braid is positioned over the sheet-wrapped mandrel, one or more tubular segments are positioned over the tubular braid, and heat shrink tubing is positioned over the tubular segments. The resulting assembly is heated to cause the tubular segments to at least partially reflow and/or otherwise laminate the tubular segments to the tubular braid and sheet. The heat shrink tubing and mandrel are then removed to create the tubular device.

Abstract: The present invention is related to a medical device carrying at least on a portion of its surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiarectic acid, resveratrol and propyl gallate, and wherein scoring or cutting balloons as medical devices are excluded.

Abstract: The present invention relates to a gene delivery stent using titanium oxide thin film coating and a method for fabricating the gene delivery stent. The gene delivery stent according to the present invention may be loaded with a drug having anti-inflammatory and anti-thrombotic effects and simultaneously deliver a gene capable of inhibiting proliferation of vascular smooth muscle cells. Accordingly, late thrombosis and metal allergy may be reduced, and vascular restenosis in the stent region may be prevented, thereby making it possible to increase treatment effects of the bare metal stent.

Abstract: A portable system for subatmospheric pressure therapy in connection with healing a surgical wound, including a wound dressing dimensioned for positioning relative to a wound bed of a subject and a subatmospheric pressure mechanism dimensioned to be carried or worn by the subject. The subatmospheric pressure mechanism includes a housing having a control unit adapted to draw a vacuum and a canister associated with the housing. The canister has a collection bag disposed therein, which is in fluid communication with the wound dressing to receive exudates from the wound bed. The collection bag is adapted to expand upon receipt of the fluids and has means to release gas from within the collection bag in connection with operation of the control unit. With this arrangement, the canister is attitude independent, i.e., the canister may be positioned on edge, on its side or on its end etc. while still maintaining operation of the control unit.

Abstract: A reduced pressure treatment apparatus includes a charging chamber storing a first pressure less than an ambient pressure and a regulated chamber storing a second pressure less than the ambient pressure. The first pressure is less than the second pressure. A conduit provides fluid communication between the regulated chamber and the charging chamber. A regulator member is operably associated with the conduit to prevent fluid communication through the conduit when the second pressure is less than or equal to a desired therapy pressure and to allow fluid communication through the conduit when the second pressure exceeds the desired therapy pressure.

Abstract: An electrical arrangement with an implantable cable element may be provided which comprises a strain relief element which is arranged centrically in the cross section, as well as a group of conductors insulated to one another, said group being stranded around the strain relief element, and a common shielding element surrounding the electrical conductors, as well as a fluid-tight cable sheath. The implantable cable element may have a symmetrical construction.

Abstract: The invention resides in the field of introducing fluid pumps into a lumen and relates to a system for introducing a pump into a lumen which comprises a first sheath and a pump to be introduced into the first sheath, or a system which has a pump with a distal pump unit and a shaft catheter which emerges proximally to the pump unit. According to the invention one or two sheaths are used, the distal pump unit being pulled firstly into the distal end of one sheath, in order to avoid damage to a shaft catheter. Subsequently, the sheath receiving the pump unit is transferred into a further sheath or a receiving lumen.

Abstract: A blood pump system and methods for the use and operation of such a blood system is described, wherein the blood pump system includes an implantable pump and an implantable flow measurement device. A processing device receives indications of a number of pump parameters such as pump voltage, pump current and pump speed. Flow rate is determined based on the pump parameters, and this determined flow rate is compared to the actual flow rate as measured by the flow measurement device. In certain embodiments, the flow measurement device may be periodically energized to make the comparison, then powered off to reduce power consumption. The time period in which the flow measurement device is powered off is based on the difference between the determined and the actual flow rates.

Abstract: The present disclosure relates to a hemodialysis membrane for the treatment of vascular calcification in hemodialysis patients, especially in chronic hemodialysis patients. The present disclosure further relates to methods of treating vascular calcification in hemodialysis patients, wherein the hemodialysis membrane is characterized in that it comprises at least one hydrophobic polymer and at least one hydrophilic polymer and in that it has a MWRO of between 15 and 20 kD and a MWCO of between 170-320 kD or that the hemodialysis membrane comprises at least one hydrophobic polymer and at least one hydrophilic polymer and has a MWRO of between 8.5 kD and 14.0 kD and a MWCO of between 55 kD and 130 kD.

Abstract: Methods and related apparatuses for sorbent recharging are provided. The methods and related apparatuses for recharging can recharge a specific rechargeable layer of a sorbent material such as zirconium phosphate in a sorbent cartridge. The methods and apparatuses include passing solutions containing combinations of acids, bases and salts through a module containing a rechargeable sorbent material such as zirconium phosphate in order to replace ions bound to the zirconium phosphate with hydrogen and sodium ions. The method allows for a customizable zirconium phosphate, with control over the ratios of sodium to hydrogen on the recharged zirconium phosphate.

Abstract: The invention relates to an arrangement having a blood pump and a gas exchanger for extracorporeal membrane oxygenation. According to the invention, the blood pump is designed as a pulsatile blood pump and is arranged with the gas exchanger in the same housing. The pulsatile blood pump and the gas exchanger are preferably connected to the same gas source so that the blood pump can be pneumatically driven. The novel ECMO system has a simple design, is flexible, and in particular can be used directly on the patient.

Abstract: Systems, methods, and compositions for removing organophosphate toxins from blood are disclosed herein. The compositions include a lipid-based capture particle that displays BChE that binds to the toxin. The methods include acoustically separating toxins bound to lipid-based capture particles from blood factors of whole blood.

Abstract: A method provided for determining a range for the amount of light-energy attenuating material that may be present in a suspension containing target cells (such as MNCs), light-energy attenuating matter (such as RBCs and plasma), and a light-energy activatable compound (such as psoralen) so that a desired therapeutic effect (such as the percentage of MNCs in which apoptosis occurs) is obtained when the suspension is subjected to a known amount of light energy. In a related aspect, a method is provided for preparing a suspension containing target cells, light-energy attenuating matter, and a light-energy activatable compound so that a desired therapeutic effect is obtained when the suspension is subjected to a known amount of light energy.

Abstract: A dose request device for a medicament delivery device can include a housing, a dose request button, a short-range non-contact identifier, a communication interface configured to communicate with the medicament delivery device, and a controller. The short-range non-contact identifier can be configured to be capable of reading an identification code from a tag when the tag is disposed within a first range and not to be able to read the identification code from the tag when the tag is disposed beyond a second range. The controller can be configured and programmed to determine whether the identification code read by the short-range non-contact identifier matches any authorized identification code of a set of one or more authorized identification codes, and if so, and if the dose request button is pressed, the controller can then communicate a dose request to the medicament delivery device via the communication interface.

Abstract: An actuator for an infusion drive mechanism comprises a piston defining a first axis and being movable within a passageway of the infusion drive mechanism to convey at least one infusion medium. The passageway defines a longitudinal axis. An armature is connected to the piston and defines at least one cavity configured for disposal of a biasing member engageable with a surface of the infusion drive mechanism to orient the first axis transverse relative to the longitudinal axis. Systems and methods of use are disclosed.

Abstract: A pumping apparatus for use with a pump set to deliver fluid through the pump set to a subject includes a pumping device capable of acting on the pump set to produce a fluid flow within the pump set. A controller is in communication with the pumping device for controlling operation of the pumping device in a feeding configuration and in a flushing configuration. The controller is adapted to store a selected flow rate and a desired fluid volume of a first fluid in the memory and at least one of a flush rate and flush volume of a second fluid. A flush time compensator is capable of being run for determining a compensated feeding configuration of the first fluid based on an amount of time the controller will operate the pump device in the flushing configuration and the desired fluid volume of the first fluid.

Abstract: Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

Abstract: An autoinjector system for injecting a fluid medicament into a patient includes a re-usable autoinjector, and a disposable cassette loaded with a hypodermic syringe pre-filled with a fluid medicament. The autoinjector includes a first motor for injecting a needle of the hypodermic syringe into the patient and a second motor for expelling the fluid medicament from the syringe.

Abstract: The present invention relates to a dose setting mechanism for a drug delivery device and a method of using same. The mechanism comprises a housing, a mechanism member movable in a first axial direction relative to the housing during dose setting and movable in a second, opposite axial direction relative to the housing during injection, wherein the mechanism member is designed and arranged such that the mechanism member is able to change its condition between a first condition preventing movement in the second axial direction and a second condition allowing movement in the second axial direction, and a switching member forcing the mechanism member to change from its second condition into its first condition at a predefined position of the movement in the first axial direction during dose setting.

Abstract: An assembly for a drug delivery device comprises a housing, a rotation member, a drive member and at least one correction member. The rotation member is adapted to be rotated with respect to the housing in a first rotational direction for delivering a dose of a drug. The drive member is coupleable to the rotation member for delivering the dose. In a delivery mode, the drive member and the rotation member are coupled such that the drive member follows rotational movement of the rotation member in the first rotational direction due to mechanical interaction of the rotation member and the drive member. In a correction mode, the rotation member and the drive member are decoupled such that the rotation member is rotatable in the first rotational direction with respect to the drive member.

Abstract: A coding system for a drug reservoir, where the drug reservoir is intended for use with a reservoir holder of a drug delivery device. The coding system includes a collar fitted around the drug reservoir. The collar includes a coding feature that is configured to pass through a corresponding coding feature provided by the reservoir holder of the drug delivery device.

Abstract: There is provided a fall detector for detecting falls of a user or an object to which the fall detector is attached, characterized in that the fall detector comprises an air flow sensor for providing measurements indicative of vertical velocity and/or changes in altitude of the fall detector.

Abstract: A method and device for delivering a pharmaceutical to the airway of a human or animal patient, in one aspect, includes a dose drum formed into a cylinder and including a plurality of dose compartments for containing individual doses. In another aspect, the device may include a reservoir containing a pharmaceutical material in bulk form and a metering recess for metering the pharmaceutical material to form a pharmaceutical dose. Another aspect provides an inhaler with a combined reservoir and dosing chamber configured to contain multiple doses of a pharmaceutical material.

Abstract: Described are systems and methods for compensating long term sensitivity drift of catalytic type electrochemical gas sensors used in systems for delivering therapeutic nitric oxide (NO) gas to a patient by compensating for drift that may be specific to the sensors atypical use in systems for delivering therapeutic nitric oxide gas to a patient. The long term sensitivity drift of catalytic type electrochemical gas sensors may be addressed using calibration schedules, which can factor in the absolute change in set dose of NO being delivered to the patient that can drive one or more baseline calibrations. The calibration schedules can be used to reduce the amount of times the sensor goes offline.

Abstract: The apparatus provides for the determination of the instantaneous phase in the respiratory cycle, subject's average respiration rate and the provision of ventilatory assistance. A microprocessor (16) receives an airflow signal from a pressure transducer (18) coupled to a port (17) at a mask (11). The microprocessor (16) controls a servo (19), that in turn controls the fan motor (20) and thus the pressure of air delivered by the blower (10). The blower (10) is coupled to a subject's mask (ii) by a conduit (12). The invention seeks to address the following goals: while the subject is awake and making substantial efforts the delivered assistance should be closely matched in phase with the subject's efforts; the machine should automatically adjust the degree of assistance to maintain at least a specified minimum ventilation without relying on the integrity of the subject's chemoreflexes; and it should continue to work correctly in the presence of large leaks.

Abstract: The invention relates to an artificial airway device (1) to facilitate lung ventilation of a patient, comprising an airway tube (2) and a mask (3) carried at one end of the airway tube, the mask (3) having a distal end (4) and a proximal end (5) and a peripheral formation (6) capable of forming a seal around the circumference of the laryngeal inlet, the peripheral formation (6) surrounding a hollow interior space or lumen (7) of the (mask (3) and the bore of the airway tube (2) opening into the lumen (7) of the mask, the airway tube including support means (44) such that the cross sectional area of the bore is substantially maintained upon application of pressure by the patient's teeth, while allowing local deformation of the tube at the point of tooth contact.

Abstract: A seal device or gasket assembly usable with respiration or ventilation mask systems and that is preferably at least one of adhesive or deformable. The gasket is disposed between the mask and the wearer and reduces the escape of respiration gases between the perimeter edge interface of the mask with the anatomy of the wearer and limits exposure of the epidermis located within the perimeter of the mask and between the mask and the wearer to the respiration gas flows. The mask system is particularly useful for improving communication of the respiration gases for those wearers having facial hair, abnormal dontia, and/or other abnormal facial features.

Abstract: In one embodiment, a nasal cannula is shaped to fit within a user's nares, where the nasal cannula includes at least one prong allowing high flow delivery of humidified gases and creates positive airway pressure in the patient's airway. The prongs have angled ends such that, in use, gases flowing through the prongs are directed to the user's nasal passages. The nasal cannula body is partially swivelling and preferably has a ball joint connector. In another embodiment the nasal cannula may have at least one flared end prong that preferably seals within a patient's nare.

Abstract: Headgear, comprising at least one strap; and at least one rigidizer, the headgear being arranged to position one of the at least one strap and one of the at least one rigidizer, with regard to one another such that the rigidizer imparts a desired shape to at least a portion of the strap while allowing said portion of the strap to move relative to the rigidizer.

Abstract: A removable water trap device (110) removes moisture from a respiratory gas stream from a patient interface assembly (140), enabling monitoring of gas within the respiratory gas stream by an analysis bench (120). The device includes a housing (111), an upstream water trap connector (115), and a filter assembly (360). The housing includes a first portion (210) insertably attachable to a tether assembly receptacle (132) to connect the device to the analysis bench for delivering the gas stream via a tether line (136). The upstream water trap connector is attachable to a downstream patient interface connector (141, 143) in a sample flow line (145, 148) of the patent interface assembly for receiving the gas stream via the sample flow line. The filter assembly is insertably contained within the housing and configured to remove moisture from the gas stream, the filter assembly including a downstream water trap connector (116) attachable with the tether line within the tether assembly receptacle.